Mr Matt Jordan

Gonville and Caius College crest
Gonville and Caius College
  • Research student
Mr Matt Jordan

About

Research

Publications

Selected publications

Mapping the patent landscape of cancer diagnostics Journal article 1 December 2025 (2025) 43(12) Nature Biotechnology 1921 Matt Jordan, Mateo Aboy, Kathleen Liddell, Cristina Crespo, Stuart Hogarth, John Powell Repositioning Generic Drugs: Empirical Findings and Policy Implications Journal article 1 September 2022 (2022) International Review of Intellectual Property and Competition Law 1 Matt Jordan, Johnathon Liddicoat, Kathleen Liddell, Johnathan Darrow, Mateo Aboy, Cristina Crespo Timo Minssen European patent protection for medical uses of known products and drug repurposing Journal article 1 April 2022 (2022) 40(4) Nature Biotechnology 465 Matt Jordan, Mateo Aboy, Kathleen Liddell, Cristina Crespo, Johnathon Liddicoat Mapping the European Patent Landscape for Medical Uses of Known Products Journal article 1 November 2021 (2021) 39(11) Nature Biotechnology 1336 Matt Jordan, Mateo Aboy, Kathleen Liddell, Johnathon Liddicoat, Cristina Crespo An empirical study of large, human biobanks: intellectual property policies and financial conditions for access Journal article 1 July 2021 (2021) 8(1) Journal of Law and the Biosciences lsab018 Matt Jordan, Johnathon Liddicoat, Kathleen Liddell IP Policies for Large Bioresources: the fiction, fantasy and future of openness Chapter 1 April 2019 In Global Genes, Local Concerns – Legal, Ethical and Scientific Challenges in International Biobanking (eds Timo Minssen, Janne Rothmar Herrmann, Jens Schovsbo), Edward Elgar Publishing Matt Jordan, Kathleen Liddell, Johnathon Liddicoat Was the Myriad decision a ‘surgical strike’ on isolated DNA patents, or does it have wider impacts? Journal article 1 December 2018 (2018) 36(12) Nature Biotechnology 1146 Matt Jordan, Mateo Aboy, Cristina Crespo. Kathleen Liddell, Johnathon Liddicoat Law and Practice of Surrogacy Conference Journal article 1 September 2018 (2018) 48(9) Family Law 1233 Matt Jordan After Myriad, what makes a gene patent ‘markedly different’ from nature? Journal article 1 September 2017 (2017) 35(9) Nature Biotechnology 820 Matt Jordan, Mateo Aboy, Johnathon Liddicoat, Kathleen Liddell, Cristina Crespo